Iversen J - Search Results

1

Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.

Ward J, Topp L, Iversen J, Wand H, Akre S, Kaldor J, Maher L. Ward J, et al. Among authors: iversen j. Aust N Z J Public Health. 2011 Oct;35(5):421-6. doi: 10.1111/j.1753-6405.2011.00743.x. Epub 2011 Sep 12. Aust N Z J Public Health. 2011. PMID: 21973248 Free article.

2

Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.

Maher L, Iversen J, Kaldor J. Maher L, et al. Among authors: iversen j. Addiction. 2006 Dec;101(12):1834-6. doi: 10.1111/j.1360-0443.2006.01666.x. Addiction. 2006. PMID: 17156184 No abstract available.

3

Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs.

Topp L, Iversen J, Conroy A, Salmon AM, Maher L; Collaboration of Australian NSPs. Topp L, et al. Among authors: iversen j. Aust N Z J Public Health. 2008 Feb;32(1):34-7. doi: 10.1111/j.1753-6405.2008.00163.x. Aust N Z J Public Health. 2008. PMID: 18290911 Free article.

4

Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey.

Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L; Collaboration of Australian Needle Syringe Programs. Topp L, et al. Among authors: iversen j. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):632-8. doi: 10.1097/qai.0b013e31816a1d68. J Acquir Immune Defic Syndr. 2008. PMID: 18491422

5

Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.

Day CA, Topp L, Iversen J, Maher L; Collaboration of Australian NSPs. Day CA, et al. Among authors: iversen j. Drug Alcohol Rev. 2008 Sep;27(5):559-61. doi: 10.1080/09595230801956132. Drug Alcohol Rev. 2008. PMID: 18608447 No abstract available.

6

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.

Kwon JA, Iversen J, Maher L, Law MG, Wilson DP. Kwon JA, et al. Among authors: iversen j. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):462-9. doi: 10.1097/QAI.0b013e3181a2539a. J Acquir Immune Defic Syndr. 2009. PMID: 19387355

7

Syringe exchange in the United States: doing the simple things better?

Maher L, Iversen J. Maher L, et al. Among authors: iversen j. Addiction. 2009 Sep;104(9):1448-50. doi: 10.1111/j.1360-0443.2009.02602.x. Epub 2009 Jun 24. Addiction. 2009. PMID: 19558566 No abstract available.

8

Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.

Iversen J, Wand H, Gonnermann A, Maher L; collaboration of Australian Needle and Syringe Programs. Iversen J, et al. Int J Drug Policy. 2010 Nov;21(6):471-6. doi: 10.1016/j.drugpo.2010.04.004. Epub 2010 May 15. Int J Drug Policy. 2010. PMID: 20472417

9

Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.

Bryant J, Topp L, Hopwood M, Iversen J, Treloar C, Maher L. Bryant J, et al. Among authors: iversen j. Drug Alcohol Rev. 2010 Jul;29(4):364-70. doi: 10.1111/j.1465-3362.2009.00154.x. Drug Alcohol Rev. 2010. PMID: 20636651

10

Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia.

Nathani J, Iversen J, Shying K, Byrne J, Maher L. Nathani J, et al. Among authors: iversen j. Drug Alcohol Rev. 2010 Jul;29(4):413-9. doi: 10.1111/j.1465-3362.2009.00165.x. Drug Alcohol Rev. 2010. PMID: 20636658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters